Endometrioid Adenocarcinoma

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

  Memorial Sloan Kettering Cancer Center is conducting an observational study to track outcomes of women with endometrial cancer receiving sta…

• CLINICAL_TRIALS trial_result · 2025-09-23
  Clinical Trial Update: Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone [Phase 2]

  Phase 2 trial in recurrent or refractory endometrial cancer evaluating Olaparib with Durvalumab, Cediranib with Durvalumab, Olaparib with Ca…

• CLINICAL_TRIALS trial_result · 2023-06-06
  Clinical Trial Update: Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers [Phase 1]

  Phase 1 trial updating on AZD1775 in combination with radiotherapy and chemotherapy for cervical, upper vaginal, and uterine cancers; study …

• CLINICAL_TRIALS trial_result · 2021-06-15
  Clinical Trial Update: A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) [Phase 2]

  Phase 2 trial ARIES evaluating rucaparib with nivolumab in selected solid tumors has been terminated; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2020-07-14
  Clinical Trial Update: Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer [Phase 2]

  Phase 2 trial evaluating cabozantinib S-Malate in recurrent or metastatic endometrial cancer has completed and results have been posted.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-03-06
  Clinical Trial Update: Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]

  Phase 2 trial evaluating copanlisib in persistent or recurrent endometrial cancer has completed with posted results.

• CLINICAL_TRIALS trial_result · 2018-04-05
  Clinical Trial Update: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Phase 1]

  A Phase 1 trial evaluating the combination of dasatinib, paclitaxel, and carboplatin in patients with Stage III-IV or recurrent endometrial …